Your browser doesn't support javascript.
loading
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization.
Zhu, Wei; Hao, Yanlei; Yuan, Zhongfang; Huang, Chunmei; Liu, Jiehui; Ma, Yan.
Affiliation
  • Zhu W; Department of Ophthalmology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China, zxyzhuwei@163.com.
  • Hao Y; Department of Ophthalmology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Yuan Z; Department of Ophthalmology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Huang C; Department of Ophthalmology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Liu J; Department of Ophthalmology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Ma Y; Department of Ophthalmology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Ophthalmic Res ; 66(1): 636-644, 2023.
Article in En | MEDLINE | ID: mdl-36746135
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choroidal Neovascularization Type of study: Observational_studies Limits: Humans Language: En Journal: Ophthalmic Res Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choroidal Neovascularization Type of study: Observational_studies Limits: Humans Language: En Journal: Ophthalmic Res Year: 2023 Document type: Article Country of publication: